Novo Nordisk cuts Wegovy's price and commits fully to its upcoming weight-loss pill to stay competitive in the fast-growing ...
Researchers monitoring the brain activity of a patient with a severe binge-eating problem reported that Eli Lilly's GLP-1 ...
Eli Lilly shares have room to keep going as GLP-1 drugs spread their reach.
Novo Nordisk plans “all in” launch of Wegovy pill in the US market and will cut price of the drug's injectable option in the ...
Signs of a weight loss price war appeared to worry investors early Monday, and Lilly and Novo stocks were down.
The maker of the weight loss and diabetes drugs Wegovy and Ozempic has cut the prices for most versions of the blockbuster ...
Trump announced popular weight loss treatments would be offered directly on a new “TrumpRx.gov” website at lower prices.
Novo Nordisk offers limited-time $199 pricing on Wegovy and Ozempic, lowers self-pay costs, and prepares for a stronger ...